General Announcement::ASX:TLX; Nasdaq: TLX - Chair Resignation, Dr Mark Nelson appointed Interim Chair

Issuer & Securities

Issuer/ Manager
TELIX PHARMACEUTICALS LIMITED
Securities
TELIXPHAR A$650M2.375%N290730 - XS2862961492 - JWQB
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
03-Feb-2026 06:07:21
Status
New
Announcement Sub Title
ASX:TLX; Nasdaq: TLX - Chair Resignation, Dr Mark Nelson appointed Interim Chair
Announcement Reference
SG260203OTHR6XXH
Submitted By (Co./ Ind. Name)
Genevieve Ryan
Designation
Company Secretary
Effective Date and Time of the event
03/02/2026 17:00:00
Description (Please provide a detailed description of the event in the box below)
ASX:TLX; Nasdaq: TLX - Chair Resignation, Dr Mark Nelson appointed Interim Chair

Attachments

20260203 Chair Appt vFINAL FINAL.pdf
Total size =191K